Related Experiment Videos
Identification of dematiaceous fungi and their role in human disease
1Department of Pathology, University of Texas Health Science Center at San Antonio, USA.
Abstract:
Phaeohyphomycosis is the disease caused by the dematiaceous hyphomycetes or those fungi that are darkly pigmented because of the presence of melanin in their cell wall. Infections with these fungi may remain localized at the site of traumatic inoculation or within the sinuses or may become disseminated. As these fungi pose a significant problem to both the clinician who must treat the patient and the laboratorian faced with identification of the organism, a selection of representative organisms was presented at the meeting entitled "Focus on Fungus Infections." These fungi often infect patients who are not overtly immunocompromised and therefore may be encountered in a wide variety of cases.
Insights
Phaeohyphomycosis, a fungal infection caused by dark-pigmented dematiaceous hyphomycetes, can be localized or disseminated. These fungi present diagnostic challenges and often affect non-immunocompromised individuals.
Area of Science:
- Mycology
- Infectious Diseases
- Medical Mycology
Background:
- Phaeohyphomycosis is caused by dematiaceous hyphomycetes, fungi characterized by dark melanin pigment in their cell walls.
- Infections can manifest locally (e.g., skin, sinuses) or become disseminated systemically.
- These fungi pose diagnostic and therapeutic challenges for healthcare professionals.
Purpose of the Study:
- To highlight representative dematiaceous fungi causing phaeohyphomycosis.
- To discuss the clinical and laboratory challenges associated with these infections.
- To emphasize the importance of recognizing these fungi in diverse patient populations.
Main Methods:
- Review of representative dematiaceous fungi causing phaeohyphomycosis.
- Discussion of clinical presentations and diagnostic considerations.
- Presentation of findings at the "Focus on Fungus Infections" meeting.
Main Results:
- Dematiaceous fungi cause a spectrum of infections, from localized to disseminated disease.
- Identification of these fungi requires specialized laboratory techniques.
- Infections occur in patients with varying degrees of immunocompromise, including those not overtly immunocompromised.
Conclusions:
- Phaeohyphomycosis is a significant clinical entity requiring accurate identification and management.
- Early recognition and diagnosis are crucial for effective treatment.
- Further research and educational initiatives are needed to address the challenges posed by these fungi.